Get the Stockscreener App
6.57
4.29%
0.27
After Hours:
6.49
-0.08
-1.22%
Nutriband Inc stock is traded at $6.57, with a volume of 38,245.
It is up +4.29% in the last 24 hours and down -18.74% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$6.30
Open:
$6.19
24h Volume:
38,245
Relative Volume:
0.30
Market Cap:
$73.28M
Revenue:
$2.09M
Net Income/Loss:
$-5.28M
P/E Ratio:
-9.806
EPS:
-0.67
Net Cash Flow:
$-3.64M
1W Performance:
-8.37%
1M Performance:
-18.74%
6M Performance:
-7.72%
1Y Performance:
+7.53%
1-Day Range:
$6.1401
$6.5972
1-Week Range:
$6.1401
$7.19
52-Week Range:
$3.7223
$11.78
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
6.57 | 70.12M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Noble Capital Markets | Outperform |
Nutriband Inc Stock (NTRB) Latest News
Who is Gareth Sheridan, the ‘pharma-bro’ hoping to be Ireland’s president? - The Times
What is the dividend yield of Nutriband Inc. Equity WarrantQuarterly Growth Report & Fast Gain Stock Trading Tips - thegnnews.com
Is Nutriband Inc. stock showing strong momentumQuarterly Earnings Summary & Expert Curated Trade Ideas - newsyoung.net
What’s the fair value of Nutriband Inc. stockWeekly Gains Report & Technical Confirmation Alerts - kangso.co.kr
After €40m losses, Nutriband faces crucial approval phase as its CEO pitches for the Áras - The Currency
Why Nutriband Inc. stock attracts strong analyst attentionMarket Growth Summary & Safe Swing Trade Setups - beatles.ru
Presidential hopeful Gareth Sheridan's Nutriband was fined by US government - MSN
Gareth Sheridan fined in 2018 for making misleading statements about his company - The Irish Times
Businessman Gareth Sheridan's wife Heidi thought their first meeting was 'absurd' - MSN
Seán Gallagher quit Nutriband after firm decided to change chairman, says Gareth Sheridan - The Irish Times
Nutriband Inc. Equity Warrant Building a Base Near Support [Market Sentiment Review]Fast Momentum Stock Entry Tips - beatles.ru
Nutriband Inc. CEO Temporarily Steps Down to Pursue Irish Presidential Candidacy - citybuzz -
Nutriband (NASDAQ: NTRB) CEO Steps Aside Temporarily To Run For Irish Presidency - Barchart.com
Nutriband (NASDAQ: NTRB) CEO Steps Aside Temporarily to Run for Irish Presidency - The Globe and Mail
Nutriband Inc. shares fall 2.37% premarket after CEO steps aside for election. - AInvest
Nutriband CEO to Step Aside Temporarily to Seek Nomination in Irish Presidential Election - MarketScreener
Navigating Leadership Shifts and Regulatory Hurdles: Nutriband's Path to AVERSA Fentanyl Commercialization - AInvest
Nutriband Inc. CEO Gareth Sheridan Takes Leave to Run for Irish Presidential Election; Serguei Melnik Appointed Interim CEO - Quiver Quantitative
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election - GlobeNewswire
Nutriband Inc. Announces CEO Changes - MarketScreener
Apple's Silence on AI Glasses and Deals: Strategic Genius or Warning Sign for Investors? - The Globe and Mail
Multi-millionaire pharma tycoon Gareth Sheridan (35) launches bid for Irish presidency - The Irish Independent
Multi-millionaire businessman Gareth Sheridan announces bid for presidency - MSN
Nutriband Inc. Company Revenue and Profit Trends: A Deep DiveTechnical Long-Term Outlook and Recap Guide - Newser
What technical models suggest about Nutriband Inc. Equity Warrant’s comebackShort Term Momentum Based Trading Strategy - Newser
Applying big data sentiment scoring on Nutriband Inc. Equity WarrantTrade Safety Report with Pattern Insights - Newser
Price Channel Expanding on Nutriband Inc.’s ChartStep-by-Step Stock Investment Guide Gains Popularity - beatles.ru
Why Nutriband Inc. Equity Warrant stock attracts strong analyst attentionFree Real Time Stock Movement Analysis - Newser
Nutriband Shares Climb After FDA Grants Meeting for Fentanyl Patch - MSN
What institutional flow reveals about Nutriband Inc.Risk Aware Trading Ideas with Alert Levels - Newser
Detecting support and resistance levels for Nutriband Inc. Equity WarrantStock Price Prediction Using AI Tools - Newser
Visualizing Nutriband Inc. Equity Warrant stock with heatmapsStock Trading Session Highlights and Summary - Newser
Nutriband Inc. Advances Toward FDA Approval for AVERSA(TM) Fentanyl Abuse-Deterrent Patch - citybuzz -
Nutriband Inc. shares fall 3.07% after-hours following FDA meeting request for Aversa Fentanyl. - AInvest
Nutriband up after FDA grants meeting for firm's fentanyl patch - TradingView
Fda Grants Nutriband Meeting Request for Aversa?? Fentanyl Abuse Deterrent Fentanyl Patch - MarketScreener
Nutriband Inc. Announces FDA Meeting for AVERSA™ FENTANYL to Discuss CMC Plans Through Commercialization - Quiver Quantitative
FDA to meet with Nutriband on abuse-deterrent fentanyl patch By Investing.com - Investing.com Australia
Nutriband stock rises after FDA grants meeting for fentanyl patch By Investing.com - Investing.com India
FDA to meet with Nutriband on abuse-deterrent fentanyl patch - Investing.com
FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch - MarketScreener
Revolutionary Abuse-Deterrent Fentanyl Patch Advances Toward FDA Review, $200M Market Potential - Stock Titan
Nutriband Completes Stock Dividend of Preferred Shares - TipRanks
Nutriband (NTRB) issues 3.0M Series A Preferred via stock dividend | NTRBW SEC FilingForm 8-K - Stock Titan
Exit strategy if you’re trapped in Nutriband Inc.Free Market Entry and Exit Point Tips - Newser
Nutriband Inc. Pioneers Abuse-Deterrent Technology for Fentanyl Delivery - citybuzz -
Nutriband (NASDAQ: NTRB) Aligns Shareholder Value With FDA Milestone - Barchart.com
Nutriband (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone - The Globe and Mail
Nutriband CEO Gareth Sheridan: “The economy is booming, but that’s a punch to the gut – when we’re a top 5 performer in every major index but our own people can’t afford to live here - Hotpress
Price action breakdown for Nutriband Inc. Equity WarrantFree Daily Volume Spike Trading Signals - Newser
What makes Nutriband Inc. Equity Warrant stock price move sharplyFree Consistent Income Focused Trade List - Newser
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):